<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="letter"><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Bioinform Biotech</journal-id><journal-id journal-id-type="publisher-id">bioinform</journal-id><journal-id journal-id-type="index">19</journal-id><journal-title>JMIR Bioinformatics and Biotechnology</journal-title><abbrev-journal-title>JMIR Bioinform Biotech</abbrev-journal-title><issn pub-type="epub">2563-3570</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">v7i1e90572</article-id><article-id pub-id-type="doi">10.2196/90572</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Letter</subject></subj-group></article-categories><title-group><article-title>Readability of AI-Generated Patient Information on Glucagon-Like Peptide-1 Receptor Agonists</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Williams</surname><given-names>Tyler</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bilic-Curcic</surname><given-names>Ines</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hurley</surname><given-names>Jonathan</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mummareddy</surname><given-names>Harisankeerth</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Cigrovski Berkovic</surname><given-names>Maja</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Canecki Varzic</surname><given-names>Silvija</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gradiser</surname><given-names>Marina</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff6">6</xref></contrib></contrib-group><aff id="aff1"><institution>Faculty of Medicine, Tulane University</institution><addr-line>New Oreleans</addr-line><addr-line>LA</addr-line><country>United States</country></aff><aff id="aff2"><institution>School of Medicine, Tulane University</institution><addr-line>New Orelans</addr-line><addr-line>LA</addr-line><country>United States</country></aff><aff id="aff3"><institution>University of Tennessee Health Science Center</institution><addr-line>Menphis</addr-line><addr-line>TN</addr-line><country>United States</country></aff><aff id="aff4"><institution>Faculty of Kinesiology, University of Zagreb</institution><addr-line>Horvacanski zavoj 15</addr-line><addr-line>Zagreb</addr-line><country>Croatia</country></aff><aff id="aff5"><institution>Faculty of Dental Medicine and Health, University of Osijek</institution><addr-line>Osijek</addr-line><addr-line>County of Osijek-Baranja</addr-line><country>Croatia</country></aff><aff id="aff6"><institution>Faculty of Medicine, University of Split</institution><addr-line>Split</addr-line><addr-line>Split-Dalmatia</addr-line><country>Croatia</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Yue</surname><given-names>Zongliang</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name name-style="western"><surname>Bethanabatla</surname><given-names>Amruthavalli</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Vundavalli</surname><given-names>Harish</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Hu</surname><given-names>Yihan</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Maja Cigrovski Berkovic, MD, Faculty of Kinesiology, University of Zagreb, Horvacanski zavoj 15, Zagreb, 10000, Croatia, 385 915128167; <email>maja.cigrovski.berkovic@kif.unizg.hr</email></corresp></author-notes><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>5</day><month>5</month><year>2026</year></pub-date><volume>7</volume><elocation-id>e90572</elocation-id><history><date date-type="received"><day>30</day><month>12</month><year>2025</year></date><date date-type="rev-recd"><day>23</day><month>03</month><year>2026</year></date><date date-type="accepted"><day>25</day><month>03</month><year>2026</year></date></history><copyright-statement>&#x00A9; Tyler Williams, Ines Bilic-Curcic, Jonathan Hurley, Harisankeerth Mummareddy, Maja Cigrovski Berkovic, Silvija Canecki Varzic, Marina Gradiser. Originally published in JMIR Bioinformatics and Biotechnology (<ext-link ext-link-type="uri" xlink:href="https://bioinform.jmir.org">https://bioinform.jmir.org</ext-link>), 5.5.2026. </copyright-statement><copyright-year>2026</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Bioinformatics and Biotechnology, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="https://bioinform.jmir.org/">https://bioinform.jmir.org/</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://bioinform.jmir.org/2026/1/e90572"/><abstract><p>Artificial intelligence (AI)&#x2013;generated content on glucagon-like peptide-1 receptor agonists (GLP-1RAs) gave informationally detailed responses, but its readability remains suboptimal for many patients. Incorporating literacy-sensitive design principles into AI health communication is essential to ensure equitable access to digital medical information.</p></abstract><kwd-group><kwd>health literacy</kwd><kwd>GLP-1RA</kwd><kwd>AI</kwd><kwd>readability</kwd><kwd>ChatGPT</kwd><kwd>Google Gemini</kwd><kwd>artificial intelligence</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have become cornerstone therapies for type 2 diabetes mellitus and obesity, with additional benefits extending to cardiovascular risk reduction and metabolic health [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>]. Their rapid clinical uptake has been paralleled by a surge in public interest and online information-seeking [<xref ref-type="bibr" rid="ref3">3</xref>-<xref ref-type="bibr" rid="ref5">5</xref>]. Artificial intelligence (AI)&#x2013;based conversational tools are increasingly used by patients as informal sources of medical guidance. However, engagement with digital health information is strongly influenced by health literacy. Patient education materials are generally recommended to be written at or below an eighth-grade reading level to ensure comprehension across diverse populations [<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref>]. Data from the OECD Survey of Adult Skills indicate that a substantial proportion of adults demonstrate limited literacy skills, raising concerns that complex digital health content may exacerbate existing health disparities [<xref ref-type="bibr" rid="ref8">8</xref>]. Given the expanding role of AI-generated medical information, evaluating whether such content is accessible to patients is crucial. This study assessed the readability of AI-generated responses to common patient questions regarding GLP-1RAs, hypothesizing that language complexity would exceed recommended thresholds for patient-facing materials.</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><p>A cross-sectional descriptive analysis was conducted using two large language models: ChatGPT (GPT-4.1; OpenAI) and Google Gemini (Gemini 2.5 Flash; Google DeepMind). Ten frequently asked patient questions related to GLP-1RAs were identified through review of online patient forums and routine clinical encounters. Topics included dosing, side effects, safety, insurance coverage, off-label use, and expected outcomes.</p><p>Each question was submitted to both models using identical prompts requesting a &#x201C;clear, patient-friendly response.&#x201D; Responses were collected verbatim between June and August 2025. All queries were submitted using the models&#x2019; web-based interfaces. Each query was entered in a new session to avoid retention of prior conversational context. No system-level prompts, role instructions, or parameter adjustments (eg, temperature, top_p) were applied; therefore, outputs reflect default model behavior as experienced by typical users. Identical prompt instructions were used for all queries across both platforms.</p><p>Readability was evaluated using three validated measures: (1) Flesch Reading Ease Score, where higher scores indicate easier readability; (2) Flesch-Kincaid Grade Level (FKGL), estimating required US school grade level; and (3) mean sentence length and word count as proxies for textual complexity.</p><p>Analyses were performed using ReadablePro software and cross-validated with Microsoft Word readability tools. In addition, two independent health communication experts qualitatively reviewed responses for tone, sentence structure, and technical language use. Paired <italic>t</italic> tests were used to compare mean readability scores between ChatGPT and Gemini responses. In addition to <italic>P</italic> values, paired mean differences with 95% CIs and effect sizes (Cohen <italic>d<sub>z</sub></italic>) were calculated to assess the magnitude of differences.</p><p>Before readability analysis, all outputs were standardized to plain text format. Formatting elements such as bullet points, headings, and line breaks were removed to ensure consistent processing across readability tools.</p><p>The full list of patient questions, verbatim model outputs, and per-question readability metrics are provided in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendices 1</xref><xref ref-type="supplementary-material" rid="app2"/>-<xref ref-type="supplementary-material" rid="app3">3</xref>.</p></sec><sec id="s3" sec-type="results"><title>Results</title><p>Across all 10 questions, both models generated detailed responses ranging from 150 to 450 words. Gemini produced shorter sentences and more concise explanations, whereas ChatGPT responses were longer and more technically detailed.</p><p>Mean Flesch Reading Ease Score was significantly higher for Gemini than for ChatGPT (47.97 vs 31.65; <italic>P</italic>=.004), indicating superior readability (<xref ref-type="fig" rid="figure1">Figure 1</xref>). Similarly, mean FKGL was lower for Gemini (10.2) compared with ChatGPT (13.1), although both exceeded the recommended eighth-grade level.</p><p>Using FKGL as the operational measure, both models exceeded the recommended &#x2264;8th-grade level for patient education materials by approximately 2&#x2010;5 grade levels on average.</p><p>Qualitative analysis revealed that ChatGPT frequently used complex sentence structures and specialized terminology, while Gemini responses adopted a more conversational tone with simpler vocabulary.</p><fig position="float" id="figure1"><label>Figure 1.</label><caption><p>Comparison of readability metrics between ChatGPT and Google Gemini responses. ChatGPT responses demonstrated lower Flesch Reading Ease Scores (FRES) and higher Flesch-Kincaid Grade Levels (FKGLs) compared to Gemini, indicating greater linguistic complexity. Both models exceeded recommended readability thresholds for patient education materials.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="bioinform_v7i1e90572_fig01.png"/></fig></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><p>This study demonstrates that AI-generated patient information on GLP-1RAs varies significantly in readability depending on the model used. Although Gemini responses were more accessible than those generated by ChatGPT, neither consistently met recommended readability standards for patient education. These findings align with prior evidence showing that online health information frequently exceeds the literacy capacity of the general population [<xref ref-type="bibr" rid="ref9">9</xref>-<xref ref-type="bibr" rid="ref12">12</xref>]. These findings also highlight limitations of general-purpose AI models in health care contexts. Domain-specific, medically trained AI agents may provide more consistent, context-aware, and clinically appropriate outputs. Such systems could incorporate structured medical knowledge, terminology control, and longitudinal context, which are critical for reliable patient communication. In clinical applications, AI systems must also include mechanisms for uncertainty management and safety. When confidence in generated responses is low, fallback strategies, such as retrieval from validated medical sources or escalation to health care professionals, are essential to ensure reliability and patient safety.</p><p>Given that AI tools prioritize completeness and accuracy, readability may be unintentionally deprioritized. Without deliberate incorporation of plain-language principles, AI-generated health content risks widening disparities among individuals with limited literacy or digital health skills.</p><p>It is important to note that outputs from large language models are highly sensitive to prompting strategies. This study intentionally used identical prompts to simulate a real-world patient scenario, in which users typically enter similar queries across platforms without advanced prompt engineering. However, more sophisticated prompting approaches or orchestration layers may yield responses with substantially different readability profiles. Future studies should explore the impact of prompt design on health communication outcomes.</p><p>AI systems also offer the potential for interactive, bidirectional communication and personalization, which may enhance patient engagement. However, without appropriate attention to readability and comprehension, these advantages may not translate into meaningful improvements in patient outcomes.</p><p>An important opportunity for future development is the integration of literacy-adaptive mechanisms within AI systems. Tailoring responses to a user&#x2019;s health literacy level, through simplified language or dynamic adjustment of complexity, could significantly enhance accessibility and patient understanding.</p><p>This study has several limitations. First, AI-generated outputs are subject to variability over time due to model updates and changes in system behavior; therefore, the findings reflect the specific models, settings, and time frame studied. Second, results may differ with alternative prompting strategies. Third, this study evaluated readability but did not assess factual accuracy or patient comprehension outcomes, which should be addressed in future research.</p><p>ChatGPT and Gemini provide clinically relevant responses on GLP-1RAs, but responses remain insufficiently readable for many patients. Integrating literacy-sensitive frameworks into AI health communication is essential to ensure equitable access to digital medical information and maximize the clinical benefits of emerging therapies.</p><p>Implementation of standardized readability frameworks within AI systems may represent a key step toward equitable digital health communication.</p></sec></body><back><notes><sec><title>Funding</title><p>The authors declared no financial support was received for this work.</p></sec></notes><fn-group><fn fn-type="conflict"><p>None declared.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">AI</term><def><p>artificial intelligence</p></def></def-item><def-item><term id="abb2">FKGL</term><def><p>Flesch-Kincaid Grade Level</p></def></def-item><def-item><term id="abb3">GLP-1RA</term><def><p>glucagon-like peptide-1 receptor agonist</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nauck</surname><given-names>MA</given-names> </name><name name-style="western"><surname>Meier</surname><given-names>JJ</given-names> </name></person-group><article-title>Incretin hormones: their role in health and disease</article-title><source>Diabetes Obes Metab</source><year>2018</year><month>02</month><volume>20 Suppl 1</volume><fpage>5</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1111/dom.13129</pub-id><pub-id pub-id-type="medline">29364588</pub-id></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilding</surname><given-names>JPH</given-names> </name><name name-style="western"><surname>Batterham</surname><given-names>RL</given-names> </name><name name-style="western"><surname>Calanna</surname><given-names>S</given-names> </name><etal/></person-group><article-title>Once-weekly semaglutide in adults with overweight or obesity</article-title><source>N Engl J Med</source><year>2021</year><month>03</month><day>18</day><volume>384</volume><issue>11</issue><fpage>989</fpage><lpage>1002</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2032183</pub-id><pub-id pub-id-type="medline">33567185</pub-id></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Javaid</surname><given-names>A</given-names> </name><name name-style="western"><surname>Baviriseaty</surname><given-names>S</given-names> </name><name name-style="western"><surname>Javaid</surname><given-names>R</given-names> </name><etal/></person-group><article-title>Trends in glucagon-like peptide-1 receptor agonist social media posts using artificial intelligence</article-title><source>JACC Adv</source><year>2024</year><month>09</month><volume>3</volume><issue>9</issue><fpage>101182</fpage><pub-id pub-id-type="doi">10.1016/j.jacadv.2024.101182</pub-id><pub-id pub-id-type="medline">39372460</pub-id></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Auerbach</surname><given-names>N</given-names> </name><name name-style="western"><surname>Liu</surname><given-names>VN</given-names> </name><name name-style="western"><surname>Huang</surname><given-names>DR</given-names> </name><name name-style="western"><surname>Clift</surname><given-names>AK</given-names> </name><name name-style="western"><surname>Al-Ammouri</surname><given-names>M</given-names> </name><name name-style="western"><surname>El-Osta</surname><given-names>A</given-names> </name></person-group><article-title>What are community perspectives and experiences around GLP-1 receptor agonist medications for weight loss? A cross-sectional survey study in the UK</article-title><source>BMJ Public Health</source><year>2025</year><volume>3</volume><issue>2</issue><fpage>e002519</fpage><pub-id pub-id-type="doi">10.1136/bmjph-2024-002519</pub-id><pub-id pub-id-type="medline">40734969</pub-id></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lipari</surname><given-names>M</given-names> </name><name name-style="western"><surname>Berlie</surname><given-names>H</given-names> </name><name name-style="western"><surname>Saleh</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Hang</surname><given-names>P</given-names> </name><name name-style="western"><surname>Moser</surname><given-names>L</given-names> </name></person-group><article-title>Understandability, actionability, and readability of online patient education materials about diabetes mellitus</article-title><source>Am J Health Syst Pharm</source><year>2019</year><month>01</month><day>25</day><volume>76</volume><issue>3</issue><fpage>182</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1093/ajhp/zxy021</pub-id><pub-id pub-id-type="medline">31408087</pub-id></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="report"><person-group person-group-type="author"><name name-style="western"><surname>Kincaid</surname><given-names>JP</given-names> </name><etal/></person-group><article-title>Derivation of new readability formulas</article-title><year>1975</year><access-date>2026-04-15</access-date><publisher-name>Naval Technical Report</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="https://apps.dtic.mil/sti/tr/pdf/ADA006655.pdf">https://apps.dtic.mil/sti/tr/pdf/ADA006655.pdf</ext-link></comment></nlm-citation></ref><ref id="ref7"><label>7</label><nlm-citation citation-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Doak</surname><given-names>CC</given-names> </name><name name-style="western"><surname>Doak</surname><given-names>LG</given-names> </name><name name-style="western"><surname>Root</surname><given-names>JH</given-names> </name></person-group><source>Teaching Patients with Low Literacy Skills</source><year>1996</year><edition>2</edition><publisher-name>J.B. Lippincott</publisher-name><pub-id pub-id-type="other">9780397544981</pub-id></nlm-citation></ref><ref id="ref8"><label>8</label><nlm-citation citation-type="web"><article-title>Survey of adult skills 2023: country note &#x2013; Croatia</article-title><source>OECD - Education GPS</source><year>2023</year><access-date>2026-04-07</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://gpseducation.oecd.org/CountryProfile?primaryCountry=HRV&#x0026;treshold=5&#x0026;topic=AS">https://gpseducation.oecd.org/CountryProfile?primaryCountry=HRV&#x0026;treshold=5&#x0026;topic=AS</ext-link></comment></nlm-citation></ref><ref id="ref9"><label>9</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernard</surname><given-names>S</given-names> </name><name name-style="western"><surname>Cooke</surname><given-names>T</given-names> </name><name name-style="western"><surname>Cole</surname><given-names>T</given-names> </name><name name-style="western"><surname>Hachani</surname><given-names>L</given-names> </name><name name-style="western"><surname>Bernard</surname><given-names>J</given-names> </name></person-group><article-title>Quality and readability of online information about type 2 diabetes and nutrition</article-title><source>JAAPA</source><year>2018</year><month>11</month><volume>31</volume><issue>11</issue><fpage>41</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1097/01.JAA.0000546481.02560.4e</pub-id><pub-id pub-id-type="medline">30358679</pub-id></nlm-citation></ref><ref id="ref10"><label>10</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yeung</surname><given-names>AWK</given-names> </name><etal/></person-group><article-title>Online information about semaglutide: mixed methods study</article-title><source>JMIR Infodemiology</source><year>2025</year><volume>5</volume><fpage>e59767</fpage><pub-id pub-id-type="doi">10.2196/59767</pub-id><pub-id pub-id-type="medline">40198905</pub-id></nlm-citation></ref><ref id="ref11"><label>11</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osborn</surname><given-names>CY</given-names> </name><name name-style="western"><surname>Bains</surname><given-names>SS</given-names> </name><name name-style="western"><surname>Egede</surname><given-names>LE</given-names> </name></person-group><article-title>Health literacy, diabetes self-care, and glycemic control in adults with type 2 diabetes</article-title><source>Diabetes Technol Ther</source><year>2010</year><month>11</month><volume>12</volume><issue>11</issue><fpage>913</fpage><lpage>919</lpage><pub-id pub-id-type="doi">10.1089/dia.2010.0058</pub-id><pub-id pub-id-type="medline">20879964</pub-id></nlm-citation></ref><ref id="ref12"><label>12</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>S&#x00F8;rensen</surname><given-names>K</given-names> </name><name name-style="western"><surname>Pelikan</surname><given-names>JM</given-names> </name><name name-style="western"><surname>R&#x00F6;thlin</surname><given-names>F</given-names> </name><etal/></person-group><article-title>Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU)</article-title><source>Eur J Public Health</source><year>2015</year><month>12</month><volume>25</volume><issue>6</issue><fpage>1053</fpage><lpage>1058</lpage><pub-id pub-id-type="doi">10.1093/eurpub/ckv043</pub-id><pub-id pub-id-type="medline">25843827</pub-id></nlm-citation></ref></ref-list><app-group><supplementary-material id="app1"><label>Multimedia Appendix 1</label><p>Patient questions used in the analysis.</p><media xlink:href="bioinform_v7i1e90572_app1.docx" xlink:title="DOCX File, 14 KB"/></supplementary-material><supplementary-material id="app2"><label>Multimedia Appendix 2</label><p>Artificial intelligence&#x2013;generated responses (verbatim).</p><media xlink:href="bioinform_v7i1e90572_app2.docx" xlink:title="DOCX File, 16 KB"/></supplementary-material><supplementary-material id="app3"><label>Multimedia Appendix 3</label><p>Supplementary table.</p><media xlink:href="bioinform_v7i1e90572_app3.docx" xlink:title="DOCX File, 14 KB"/></supplementary-material></app-group></back></article>